MURYEL VARY: Open Payments
NPI 1881086742 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 19 payments from 8 companies in 2025. Trend: 2023 $1,802 · 2024 $1,662 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $88 |
| Abbott Laboratories | 3 | $82 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Lilly USA, LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $15 |
| Viatris Specialty LLC | 1 | $15 |
Products named: FREESTYLE LIBRE 2, TRELEGY ELLIPTA, Wegovy, MOUNJARO, Auvelity, REXULTI, Dexcom G6 Transmitter, YUPELRI.
Industry payments across NC — which companies pay providers there.
